JPS63500661A - 新規ビタミンd類似体 - Google Patents
新規ビタミンd類似体Info
- Publication number
- JPS63500661A JPS63500661A JP61504410A JP50441086A JPS63500661A JP S63500661 A JPS63500661 A JP S63500661A JP 61504410 A JP61504410 A JP 61504410A JP 50441086 A JP50441086 A JP 50441086A JP S63500661 A JPS63500661 A JP S63500661A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- triene
- seco
- enyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (14)
- 1.式: ▲数式、化学式、表等があります▼ [式中、Xは水素、C1−C8アルキル、ハロゲンまたはヒドロキシ;Yは水素 またはヒドロキシ;R1およびR2は、同−または異なって、ハロゲンもしくは ヒドロキシで置換されていることもあるC1−C8アルキル(ただし、XがC1 −C8アルキルでない場合には、R1およびR2が両方ともメチルであることは ない。)を表し、またはR1およびR2はC−25と共に、可能ないずれかの位 置でCl−C8アルキル、ハロゲンもしくはヒドロキシで置換されていることも ある飽和もしくは不飽和のC3−C9炭素環(芳香族環を含む。)を形成し得; R3は水素またはC1−C6アルキル;R4およびR5はいずれも水素であるか 、またはC−22とC−23の間に二重結合を形成するように結合している。〕 で示される化合物(I);並びにその生可逆的誘導体。
- 2.結晶形である第1項記載の化合物。
- 3.R3が水素またはメチルである式(I)で示される第1項記載の化合物。
- 4.R4およびR5が、C−22とC−23の間にトランス立体配置を有する二 重結合を形成するように結合している第3項記載の化合物。
- 5.(1′E,3R,5Z,7E,20R)−9,10−セコ−20−(3′− シクロプロピル−3′−ヒドロキシブロパ−1′−エニル)−3−ヒドロキシプ レグナ−5,7,10(19)−トリエン;(1S,1′E,3R,5Z,7E ,20R)−9,10−セコ−20−(3′−シクロプロピル−3′−ヒドロキ シブロパ−1′−エニル)−1,3−ジヒドロキシプレグナ−5,7,10(1 9)−トリエン;(1S,1′E,3R,5Z,7E,20R)−9,10−セ コ−20−(3′−シクロペンチル−3′−ヒドロキシプロパ−1′−エニル) −1,3−ジヒドロキシプレグナ−5,7,10(19)−トリエン;(1S, 1′E,3R,5Z,7E,20R)−9,10−セコ−20−(3′−シクロ ヘキシル−3′−ヒドロキシプロパ−1′−エニル)−1,3−ジヒドロキシプ レグナ−5,7,10(19)−トリエン;(1S,1′E,3R,5Z,7E ,20R)−9,10−セコ−20−(4′,4′−ジメチル−3′−ヒドロキ シペンタ−1′−エニル)−1,3−ジヒドロキシプレグナ−5,7,10(1 9)−トリエン;(1S,1′E,3R,5Z,7E,20R)−9,10−セ コ−20−(3′−フェニル−3′−ヒドロキシプロパ−1′−エニル)−1, 3−ジヒドロキシプレグナ−5,7,10(19)−トリエン;(1S,3R, 5Z,7E,20R)−9,10−セコ−(3′−シクロプロピル−3′−ヒド ロキシプロピル)−1,3−ジヒドロキシブレグナ−5,7,10(19)−ト リエン;(1S,1′E,3R,5Z,7E,20R)−9,10−セコ−20 −(3′−シクロプロピル−3′−ヒドロキシブタ−1′−エニル)−1,3− ジヒドロキシプレグナ−5,7,10(19)−トリエンの3′Rおよび3′S 異性体から成る群から選択される第1項記載の化合物。
- 6.第1項記載の化合物の製造方法であって、式(IV):▲数式、化学式、表 等があります▼(IV)[式中、R1、R1、R3、R4およびR5は前記と同 意義、[X]は、前記と同意義のX、または後にXに変換し得る保護もしくはマ スクされた誘導基、Z′は要すれば保護された水酸基、およびZはHまたは要す れば保護された水酸基を表す。]で示される化合物を、トリプレット増感光異性 化に付し、および要すれば水酸基の脱保護を行うことを含んで成り、これらの反 応を適宜行う製造方法。
- 7.第6項記載の化合物(IV)の製造方法であって、式(N):▲数式、化学 式、表等があります▼(N)[式中、Z′およびZは前記と同意義である。]で 示される化合物を、式(D): ▲数式、化学式、表等があります▼(D)で示される化合物と反応させ、要すれ ば次いで22,23−二重結合を還元し、還元剤(R3=水素)または有機金属 試薬(R3=アルキル)で処理することによって24−オキソ化合物を24−ヒ ドロキシ化合物(IV)に変換することを含んで成る製造方法。
- 8.第1項記載の化合物(I)の製造方法であって、要すれば1個またはそれ以 上の保護水酸基を有する対応するプレビタミンを熱異性化に付し、要すれば次い で水酸基の脱保護を行うことを含んで成る製造方法。
- 9.(3R,5E,7E,20S)−9,10−セコ−20−ホルミル−3−( t−ブチルジメチルシリルオキシ)プレグナ−5,7,10(19)−トリエン ;または (1S,3R,5E,7E,20R)−9,10−セコ−20−ホルミル−1, 3−ビス(t−ブチルジメチルシリルオキシ)プレグナ−5,7,10(19) −トリエン である第7項記載の化合物(N)。
- 10.第1項記載の化合物(I)の1種またはそれ以上の有効量を、薬学的に許 容し得る無毒性担体および/または助剤と共に含有する医薬製剤。
- 11.外用である第10項記載の医薬製剤。
- 12.経口投与用である第10項記載の医薬製剤。
- 13.異常細胞増殖および/または細胞分化を特徴とする病気の患者を治療する 方法であって、治療を要する患者に第10項記載の製剤を投与することを含んで 成る治療方法。
- 14.乾癬の患者を第11項記載の製剤で治療する第13項記載の治療方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858519502A GB8519502D0 (en) | 1985-08-02 | 1985-08-02 | Chemical compounds |
GB8519502 | 1985-08-02 | ||
PCT/DK1986/000081 WO1987000834A1 (en) | 1985-08-02 | 1986-07-14 | Novel vitamin d analogues |
PH34061A PH25496A (en) | 1985-08-02 | 1986-08-11 | New vitamin d analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63500661A true JPS63500661A (ja) | 1988-03-10 |
JPH07100685B2 JPH07100685B2 (ja) | 1995-11-01 |
Family
ID=26289597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61504410A Expired - Lifetime JPH07100685B2 (ja) | 1985-08-02 | 1986-07-14 | 新規ビタミンd類似体 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4866048A (ja) |
EP (1) | EP0227826B1 (ja) |
JP (1) | JPH07100685B2 (ja) |
KR (1) | KR940010767B1 (ja) |
AU (1) | AU603340B2 (ja) |
CA (1) | CA1307288C (ja) |
DE (1) | DE3666587D1 (ja) |
DK (1) | DK166617B1 (ja) |
ES (1) | ES2000823A6 (ja) |
GR (1) | GR862029B (ja) |
HK (1) | HK63492A (ja) |
IE (1) | IE58545B1 (ja) |
PH (1) | PH25496A (ja) |
PT (1) | PT83119B (ja) |
SG (1) | SG64192G (ja) |
WO (1) | WO1987000834A1 (ja) |
Families Citing this family (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4728643A (en) * | 1984-11-02 | 1988-03-01 | The General Hospital Corporation | Method of treating psoriasis |
GB2183156B (en) * | 1985-03-14 | 1989-06-21 | Chugai Pharmaceutical Co Ltd | Composition for treating skin disease |
FR2631025B1 (fr) * | 1988-05-04 | 1991-04-12 | Ire Medgenix Sa | Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3 |
GB8816505D0 (en) * | 1988-07-12 | 1988-08-17 | Leo Pharm Prod Ltd | Novel treatment |
US4851401A (en) * | 1988-07-14 | 1989-07-25 | Wisconsin Alumni Research Foundation | Novel cyclopentano-vitamin D analogs |
GB8904154D0 (en) | 1989-02-23 | 1989-04-05 | Leo Pharm Prod Ltd | Chemical compounds |
ES2055521T3 (es) * | 1990-02-06 | 1994-08-16 | Schering Ag | Derivados de vitamina d que son homologos en la cadena lateral, procedimiento para su preparacion, preparados farmaceuticos que contienen estos derivados asi como su utilizacion como medicamentos. |
US5260290A (en) * | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
GB9015774D0 (en) * | 1990-07-18 | 1990-09-05 | Leo Pharm Prod Ltd | Novel treatment |
GB9017890D0 (en) | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
US5763428A (en) * | 1990-09-21 | 1998-06-09 | Bone Care International, Inc. | Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof |
US6025346A (en) * | 1990-09-21 | 2000-02-15 | Bone Care International, Inc. | 1α-hydroxy vitamin D4 and novel intermediates and analogues |
US5798345A (en) * | 1990-09-21 | 1998-08-25 | Bone Care International, Inc. | Method of inhibiting the hyperproliferation of malignant cells |
WO1992005130A1 (en) * | 1990-09-21 | 1992-04-02 | Lunar Corporation | NOVEL 1α-HYDROXY VITAMIN D4 AND NOVEL INTERMEDIATES AND ANALOGUES |
US5801164A (en) * | 1990-09-21 | 1998-09-01 | Bone Care International, Inc. | Methods of treating osteoporosis prophylactically or therapeutically |
US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
US5786348A (en) * | 1991-01-08 | 1998-07-28 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2 |
US6166000A (en) * | 1991-01-08 | 2000-12-26 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-Dihydroxy vitamin . D.sub2 |
WO1992012165A1 (en) * | 1991-01-08 | 1992-07-23 | Lunar Corporation | METHODS FOR PREPARATION AND USE OF 1α,24-DIHYDROXY VITAMIN D¿2? |
US5182396A (en) * | 1991-03-29 | 1993-01-26 | Nisshin Flour Milling Co., Ltd. | 1-hydroxyvitamin d derivatives |
AU650751B2 (en) * | 1991-05-28 | 1994-06-30 | Wisconsin Alumni Research Foundation | Novel synthesis of 19-nor vitamin D compounds |
ES2093180T3 (es) * | 1991-07-05 | 1996-12-16 | Duphar Int Res | Compuesto de vitamina d, metodo de preparar este compuesto y producto intermedio de dicho metodo. |
US5225569A (en) * | 1991-08-09 | 1993-07-06 | Hoffmann-La Roche Inc. | Process for precursors to calcitriol and related compounds |
US5182393A (en) * | 1991-08-09 | 1993-01-26 | Hoffmann-La Roche Inc. | Process for precursors to calcitriol and related compounds |
IL107185A (en) * | 1992-10-06 | 1998-02-22 | Schering Ag | History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them |
US5288408A (en) * | 1992-10-26 | 1994-02-22 | Chemical Industry Consultants, Inc. | Method of gelatin recovery and purification from encapsulation processes |
US5247104A (en) * | 1992-11-04 | 1993-09-21 | Wisconsin Alumni Research Foundation | Preparation of 1α, 24-dihydroxyvitamin D analogs |
USRE39706E1 (en) * | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
US5449668A (en) * | 1993-06-04 | 1995-09-12 | Duphar International Research B.V. | Vitamin D compounds and method of preparing these compounds |
DE4328217C2 (de) * | 1993-08-21 | 1996-01-11 | Lohmann Therapie Syst Lts | Therapeutisches System zur Behandlung der Psoriasis |
US5763429A (en) | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
US5565589A (en) * | 1993-11-03 | 1996-10-15 | Wisconsin Alumni Research Foundation | 17-formyl-5,6-trans-vitamin D compounds |
US5373004A (en) * | 1993-11-24 | 1994-12-13 | Wisconsin Alumni Research Foundation | 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds |
WO1996002501A1 (en) * | 1994-07-18 | 1996-02-01 | Lunar Corporation | SYNTHESIS OF 1α-HYDROXY VITAMIN D |
DK128494A (da) * | 1994-11-08 | 1996-05-09 | Edel K Seidenschnur | Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat |
US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
CH690075A5 (de) * | 1995-07-11 | 2000-04-14 | Cerbios Pharma Sa | Verfahren zur Herstellung von 9,10-Secocholesta-5, 7, 10 (19)-trienen durch Reduktion der Epoxide. |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US20030129194A1 (en) * | 1997-02-13 | 2003-07-10 | Bone Care International, Inc. | Targeted therapeutic delivery of vitamin D compounds |
PL336231A1 (en) | 1997-02-13 | 2000-06-19 | Bone Care International | System for aimed therapeutic delivery of vitamin d compounds |
DE19744127B4 (de) | 1997-10-01 | 2006-10-05 | Schering Ag | Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln |
AU743582B2 (en) | 1997-12-09 | 2002-01-31 | Chugai Seiyaku Kabushiki Kaisha | Lotions containing vitamin D3 derivatives |
CA2326117A1 (en) | 1998-03-27 | 1999-10-07 | Oregon Health Sciences University | Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6552009B2 (en) | 1998-07-16 | 2003-04-22 | Gentrix Llc | Compositions and methods of treating abnormal cell proliferation |
US20010002396A1 (en) * | 1998-07-16 | 2001-05-31 | Charles Achkar | Compositions and methods of treating skin conditions |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US6410746B1 (en) * | 1999-04-27 | 2002-06-25 | Research Foundation Of State University Of New York, The | Metal cataltsts and methods for making and using same |
US6617681B1 (en) * | 1999-06-28 | 2003-09-09 | Intel Corporation | Interposer and method of making same |
US6524623B1 (en) | 1999-11-12 | 2003-02-25 | Milton Hodosh | Therapeutic compositions and methods of use thereof |
JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化1α−ヒドロキシビタミンD |
US6962891B2 (en) | 2001-08-27 | 2005-11-08 | The Research Foundation Of State University Of New York | Solid support dirhodium catalyst compositions and methods for making and using same |
US7030051B2 (en) | 2001-08-27 | 2006-04-18 | The Research Foundation Of State University Of New York | Dirhodium catalyst compositions and methods for using same |
DE10156596A1 (de) * | 2001-11-13 | 2003-05-28 | Schering Ag | Vitamin D-Derivate mit Acyloxygruppen in der Seitenkette, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
KR20050044655A (ko) * | 2001-12-03 | 2005-05-12 | 노바세아, 인크. | 활성 비타민 d 화합물을 함유하는 약제학적 조성물 |
IL162920A0 (en) * | 2002-01-10 | 2005-11-20 | Va Pharmaceutical Ind Ltd | Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
EP1497264A2 (en) * | 2002-04-11 | 2005-01-19 | Instytut Farmaceutyczny | Preparation of 24-alkyl analogs of cholecalciferol and non-racemic compounds |
US7205420B2 (en) * | 2002-06-13 | 2007-04-17 | Teva Pharmaceutical Industries Ltd. | Epimerization of analogs of vitamin D |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
EP1458678A1 (en) * | 2002-11-18 | 2004-09-22 | Teva Pharmaceutical Industries Limited | A crystallization method for purification of calcipotriene |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
US20050153941A1 (en) * | 2003-06-27 | 2005-07-14 | Tomoyuki Miyabayashi | Cell differntiation inhibiting agent, cell culture method using the same, culture medium, and cultured cell line |
PL1656372T3 (pl) | 2003-07-30 | 2013-08-30 | Rigel Pharmaceuticals Inc | Związki 2,4-pirymidynodiaminy do stosowania w leczeniu lub zapobieganiu chorobom autoimmunologicznym |
US7205006B2 (en) * | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
PL1730108T3 (pl) * | 2004-03-18 | 2008-09-30 | Leo Pharma As | Stereoselektywna synteza analogów witaminy D |
MY139521A (en) | 2004-03-18 | 2009-10-30 | Leo Pharma As | Stereoselective synthesis of vitamin d analogues |
DE05715124T1 (de) * | 2004-04-02 | 2008-02-21 | Leo Pharma A/S | Neues verfahren zur herstellung von für die synthese von vitamin-d-analoga geeigneten zwischenprodukten |
US7094775B2 (en) | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
TWI318203B (en) * | 2004-09-01 | 2009-12-11 | Leo Pharma As | Epimerization of allylic alcohols |
AU2005303773A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer |
JP2006204292A (ja) * | 2004-12-27 | 2006-08-10 | Asahi Kasei Corp | ヒト胚性幹細胞分化抑制剤 |
AU2006245282A1 (en) * | 2005-05-10 | 2006-11-16 | Dermipsor Ltd. | Compositions and methods for skin care |
EP1879595B1 (en) | 2005-05-10 | 2014-09-24 | Dermipsor Ltd | Compositions and methods for treating hyperproliferative epidermal diseases |
EP1917072B1 (en) * | 2005-06-01 | 2013-02-27 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US7700798B1 (en) | 2005-06-08 | 2010-04-20 | The Research Foundation Of State University Of New York | Erogorgiaene congeners and methods and intermediates useful in the preparation of same |
US7816536B2 (en) * | 2005-06-10 | 2010-10-19 | The Research Foundation Of State University Of New York | 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same |
WO2006135915A2 (en) | 2005-06-13 | 2006-12-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for treating degenerative bone disorders |
WO2006138056A1 (en) * | 2005-06-15 | 2006-12-28 | Apollo Pharmaceutical, Inc. | Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis |
ATE352714T1 (de) * | 2005-06-17 | 2007-02-15 | Magneti Marelli Powertrain Spa | Brennstoffeinspritzventil |
TW200714580A (en) * | 2005-10-14 | 2007-04-16 | Formosa Lab Inc | Process for preparing vitamin D analogs |
US7385064B1 (en) | 2005-11-30 | 2008-06-10 | The Research Foundation Of State University Of New York | Catalysts for use in enantioselective synthesis |
CA2646856C (en) | 2006-03-17 | 2013-05-07 | Leo Pharma A/S | Isomerisation of pharmaceutical intermediates |
US20080051380A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
US20080051375A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
KR20090060306A (ko) | 2006-08-25 | 2009-06-11 | 코우가 바이오테크놀로지, 인크. | 비타민 d 화합물 및 추가 치료제, 및 그를 함유하는 조성물을 투여하는 것을 포함하는, 암을 치료하는 방법 |
BRPI0715636A2 (pt) * | 2006-08-29 | 2013-07-02 | Teva Pharma | composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo |
ES2272198B1 (es) * | 2006-12-28 | 2008-06-01 | Laboratorios Viñas S.A. | Procedimiento para la obtencion de hidrato de calcipotriol. |
WO2009009132A1 (en) * | 2007-07-12 | 2009-01-15 | Cougar Biotechnology, Inc. | Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer |
US8716334B2 (en) * | 2008-06-17 | 2014-05-06 | Ben Gurion University Of The Negev Research And Development Authority | Substituted cyclohexylidene-ethylidene-octahydro-indene compounds |
KR101991692B1 (ko) | 2009-01-27 | 2019-06-21 | 베르그 엘엘씨 | 화학요법과 연관된 부작용을 경감시키기 위한 비타민 d3 및 이의 유사물 |
US20120184514A1 (en) * | 2009-07-01 | 2012-07-19 | Vitamin Derivatives Inc. | Vitamin d compounds and methods for preparing same |
EA201270226A1 (ru) | 2009-08-14 | 2012-09-28 | БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи | Витамин d3 и его аналогии для лечения алопеции |
WO2011079249A2 (en) * | 2009-12-23 | 2011-06-30 | Glycomyr, Inc. | Use of vitamin d glycosides and sulfates for treatment of disease |
WO2012158794A1 (en) | 2011-05-17 | 2012-11-22 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses |
CN103508999B (zh) | 2013-10-12 | 2015-05-13 | 浙江海正药业股份有限公司 | 马沙骨化醇的合成中间体及其制备方法和用途 |
CN103694156B (zh) * | 2014-01-07 | 2015-09-02 | 成都医路康医学技术服务有限公司 | 一种银屑病治疗药物钙泊三醇的制备方法 |
CN105348164B (zh) * | 2015-10-29 | 2017-03-29 | 无锡福祈制药有限公司 | 一种1α‑羟基维生素D2的制备方法 |
US20190183908A1 (en) | 2016-05-13 | 2019-06-20 | Case Western Reserve University | Autophagy activators for treating or preventing skin injury |
CN107501150A (zh) * | 2016-06-14 | 2017-12-22 | 江苏吉贝尔药业股份有限公司 | 两种他卡西醇中间体的制备方法 |
UA124972C2 (uk) | 2016-07-29 | 2021-12-22 | Янссен Фармацевтика Нв | Способи лікування раку передміхурової залози |
CN110156836A (zh) * | 2019-06-10 | 2019-08-23 | 成家钢 | 一种环丙基羰基亚甲基三苯基磷的制备方法 |
CN111662221B (zh) * | 2020-06-29 | 2022-04-19 | 重庆华邦胜凯制药有限公司 | 一种卡泊三醇杂质的制备方法 |
CN115177586A (zh) * | 2022-08-31 | 2022-10-14 | 江苏知原药业股份有限公司 | 一种卡泊三醇组合物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5945673B2 (ja) * | 1978-01-16 | 1984-11-07 | ウイスコンシン・アラムナイ・リサ−チ・フオンデ−シヨン | シクロビタミンd誘導体 |
US4195027A (en) * | 1978-01-16 | 1980-03-25 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4225596A (en) * | 1978-10-13 | 1980-09-30 | Wisconsin Alumni Research Foundation | Method for treating calcium imbalance and improving calcium absorption in mammals |
US4335120A (en) * | 1979-03-21 | 1982-06-15 | Hoffmann-La Roche Inc. | Administration of biologically active vitamin D3 and vitamin D2 materials |
JPS57109765A (en) * | 1980-12-27 | 1982-07-08 | Wisconsin Alumni Res Found | Preparation of 1-hydroxylated vitamin d compound from 5,6-trans-vitamin d compound |
JPS57149224A (en) * | 1981-03-13 | 1982-09-14 | Chugai Pharmaceut Co Ltd | Tumor-suppressing agent |
US4442093A (en) * | 1981-05-15 | 1984-04-10 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia |
JPS58208224A (ja) * | 1982-05-28 | 1983-12-03 | Kureha Chem Ind Co Ltd | 抗腫瘍剤 |
JPS59104358A (ja) * | 1982-12-03 | 1984-06-16 | Teijin Ltd | 1α,24−ジヒドロキシコレカルシフエロ−ルの一水塩及びその製造法 |
US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
JPS59186956A (ja) * | 1983-04-07 | 1984-10-23 | Teijin Ltd | 24−ヒドロキシ−25−デヒドロビタミンd↓3類、その製造法及びそれを有効成分とするカルシウム調節剤 |
US4728643A (en) * | 1984-11-02 | 1988-03-01 | The General Hospital Corporation | Method of treating psoriasis |
US4661294A (en) * | 1985-03-18 | 1987-04-28 | The General Hospital Corporation | Biologically active 1-thio derivatives of vitamin D |
-
1986
- 1986-07-14 WO PCT/DK1986/000081 patent/WO1987000834A1/en active IP Right Grant
- 1986-07-14 KR KR1019870700233A patent/KR940010767B1/ko not_active IP Right Cessation
- 1986-07-14 EP EP86904788A patent/EP0227826B1/en not_active Expired
- 1986-07-14 DE DE8686904788T patent/DE3666587D1/de not_active Expired
- 1986-07-14 US US07/034,391 patent/US4866048A/en not_active Expired - Lifetime
- 1986-07-14 AU AU61961/86A patent/AU603340B2/en not_active Expired
- 1986-07-14 JP JP61504410A patent/JPH07100685B2/ja not_active Expired - Lifetime
- 1986-07-15 IE IE189486A patent/IE58545B1/en not_active IP Right Cessation
- 1986-07-30 CA CA000515024A patent/CA1307288C/en not_active Expired - Lifetime
- 1986-07-31 GR GR862029A patent/GR862029B/el unknown
- 1986-08-01 PT PT83119A patent/PT83119B/pt unknown
- 1986-08-01 ES ES8600822A patent/ES2000823A6/es not_active Expired
- 1986-08-11 PH PH34061A patent/PH25496A/en unknown
-
1987
- 1987-03-20 DK DK142987A patent/DK166617B1/da not_active IP Right Cessation
-
1992
- 1992-06-23 SG SG641/92A patent/SG64192G/en unknown
- 1992-08-20 HK HK634/92A patent/HK63492A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK63492A (en) | 1992-08-28 |
US4866048A (en) | 1989-09-12 |
AU6196186A (en) | 1987-03-05 |
IE58545B1 (en) | 1993-10-06 |
DK142987A (da) | 1987-03-20 |
GR862029B (en) | 1986-12-24 |
WO1987000834A1 (en) | 1987-02-12 |
PT83119B (pt) | 1989-03-30 |
DK142987D0 (da) | 1987-03-20 |
ES2000823A6 (es) | 1988-03-16 |
JPH07100685B2 (ja) | 1995-11-01 |
DE3666587D1 (en) | 1989-11-30 |
KR940010767B1 (ko) | 1994-11-11 |
DK166617B1 (da) | 1993-06-21 |
KR870700600A (ko) | 1987-12-30 |
EP0227826B1 (en) | 1989-10-25 |
PH25496A (en) | 1991-07-24 |
EP0227826A1 (en) | 1987-07-08 |
AU603340B2 (en) | 1990-11-15 |
IE861894L (en) | 1987-02-02 |
SG64192G (en) | 1992-09-04 |
CA1307288C (en) | 1992-09-08 |
PT83119A (en) | 1986-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63500661A (ja) | 新規ビタミンd類似体 | |
JPH04506965A (ja) | 新規ビタミンd類似体 | |
RU2037484C1 (ru) | Аналог витамина д | |
DE4141746A1 (de) | 20-methyl-substituierte vitamin d-derivate | |
JPH03501259A (ja) | 新規なシクロペンタノ‐ビタミンd類似体 | |
US5532228A (en) | Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents | |
US4897387A (en) | Novel vitamin D3 derivatives | |
JPS61502257A (ja) | 1,24―ジヒドロキシ―△22―ビタミンd3化合物 | |
US6448421B1 (en) | Crystals of vitamin D derivatives and process for the preparation thereof | |
US5401732A (en) | Vitamin D analogues | |
HRP20020007A2 (en) | Vitamin d3 analogs | |
EP0245524B1 (en) | Vitamin d 3 derivative | |
NZ250194A (en) | Vitamin d3 analogues; compounds, preparation and pharmaceutical compositions | |
JPH05501718A (ja) | 側鎖同族体ビタミン―d―誘導体、その製造法ならびに該誘導体を含有する、過増殖を示す疾病を治療するための製薬学的調製剤 | |
JPS62501505A (ja) | ビタミンd誘導体 | |
US4929609A (en) | 25, 28-dihydroxyergocalciferol and 1,25,28-trihydroxyergocalciferol compositions thereof and their use in the treatment of hyperproliferative disease | |
JPH1072432A (ja) | ビタミンd誘導体結晶およびその製造方法 | |
JP3579209B2 (ja) | 20−エピ−22(r)−低級アルキルビタミンd誘導体およびそれを有効成分とするカルシウム代謝改善剤 | |
JPH0625155A (ja) | 22−メチルビタミンd誘導体 | |
KR100554560B1 (ko) | 비타민d유도체결정및그의제조방법 | |
JP2001089442A (ja) | 活性型ビタミンd誘導体 | |
EP1174424A1 (en) | 3-methylated vitamin d derivatives | |
US20050119240A1 (en) | 1-methyl-20-epi-vitamin d derivative | |
JPWO2003055854A1 (ja) | 2位に置換基を有するビタミンd誘導体 | |
JPH11246520A (ja) | 20−エピ−22−エチル−23,24−デヒドロ−24,24−ジホモビタミンd誘導体及びその合成中間体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081101 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091101 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091101 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101101 Year of fee payment: 15 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101101 Year of fee payment: 15 |